Xiang Luo
Clinical trials sponsored by Xiang Luo, explained in plain language.
-
New drug duo aims to stop stroke damage in its tracks
Disease control Recruiting nowThis study tests whether giving a powerful cholesterol-lowering drug (evolocumab) along with standard statins within 48 hours of a stroke can prevent early brain function decline. About 429 adults with moderate-to-severe artery narrowing in the brain will be randomly assigned to …
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated May 26, 2026 04:44 UTC
-
New stroke treatment targets medium blockages with targeted drug delivery
Disease control Recruiting nowThis study tests whether giving a clot-dissolving drug directly into the brain's arteries can improve recovery for people with acute stroke caused by medium-sized vessel blockages. About 382 adults who have had a stroke within the last 24 hours will be randomly assigned to receiv…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated May 26, 2026 04:43 UTC